189 related articles for article (PubMed ID: 18718855)
1. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
[TBL] [Abstract][Full Text] [Related]
2. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
3. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
[TBL] [Abstract][Full Text] [Related]
4. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rat OX40 ligand by monoclonal antibody.
Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of OX40 expressed on human CD8+ T cells.
Fujita T; Ukyo N; Hori T; Uchiyama T
Immunol Lett; 2006 Jul; 106(1):27-33. PubMed ID: 16750861
[TBL] [Abstract][Full Text] [Related]
7. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of IL-17 production by OX40/OX40L interaction.
Li J; Li L; Shang X; Benson J; Merle Elloso M; Schantz A; Bracht M; Orlovsky Y; Sweet R
Cell Immunol; 2008; 253(1-2):31-7. PubMed ID: 18501882
[TBL] [Abstract][Full Text] [Related]
9. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
al-Shamkhani A; Birkeland ML; Puklavec M; Brown MH; James W; Barclay AN
Eur J Immunol; 1996 Aug; 26(8):1695-9. PubMed ID: 8765008
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of the inducible costimulator ligand B7-H2 in human airway smooth muscle cells.
Kajiwara K; Morishima H; Akiyama K; Yanagihara Y
Allergol Int; 2009 Dec; 58(4):573-83. PubMed ID: 19776675
[TBL] [Abstract][Full Text] [Related]
11. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
12. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA.
Mestas J; Crampton SP; Hori T; Hughes CC
Int Immunol; 2005 Jun; 17(6):737-47. PubMed ID: 15908450
[TBL] [Abstract][Full Text] [Related]
14. Identification of rat OX40 ligand by molecular cloning.
Akiba H; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 1998 Oct; 251(1):131-6. PubMed ID: 9790919
[TBL] [Abstract][Full Text] [Related]
15. Bidirectional modulation of human B cell stimulation by activated T cells.
Hirohata S; Shinohara S
Cell Immunol; 1993 Sep; 150(2):257-68. PubMed ID: 8370072
[TBL] [Abstract][Full Text] [Related]
16. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals.
Song A; Song J; Tang X; Croft M
Eur J Immunol; 2007 May; 37(5):1224-32. PubMed ID: 17429847
[TBL] [Abstract][Full Text] [Related]
17. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
18. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
[TBL] [Abstract][Full Text] [Related]
19. Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation.
Tsukahara R; Takeuchi M; Akiba H; Kezuka T; Takeda K; Usui Y; Usui M; Yagita H; Okumura K
Int Immunol; 2005 May; 17(5):523-30. PubMed ID: 15778288
[TBL] [Abstract][Full Text] [Related]
20. Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions.
Pakala SV; Bansal-Pakala P; Halteman BS; Croft M
Eur J Immunol; 2004 Nov; 34(11):3039-46. PubMed ID: 15368274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
